SO

Scott Oppenheim

Senior Director Of Supply Chain at Harrow Health

Scott Oppenheim has over 20 years of experience in supply chain management and operations. Scott is currently serving as the Senior Director of Supply Chain at ImprimisRx since April 2022. Prior to this, they worked at Hitachi Chemical Advanced Therapeutics Solutions, LLC from April 2019 to April 2022, holding the positions of Director of Operations and Supply Chain Director. In these roles, they led a complete overhaul of the supply chain department and implemented major electronic systems to improve efficiency and productivity. From January 2013 to April 2016, Scott was a Supply Chain Manager at Novartis, where they directed critical path planning and scheduling activities for high-profile manufactured products. Scott managed a team of over 100 employees and was responsible for maintaining ongoing production levels. Before that, they worked at Dendreon Corporation as an Operations Manager from June 2009 to January 2013, where they were responsible for scheduling and planning the first commercialized cell and gene therapy product. Scott also has experience as a Supply Chain Manager at SPX Corporation from November 2006 to April 2009, where they managed various supply chain functions for an aerospace supply firm. Scott started their career at POP Displays in April 1999 as a Planning/Purchasing/Inventory Control Manager, where they created and maintained production schedules and managed all planning and purchasing activities. Overall, Scott has demonstrated expertise in supply chain management, strategic planning, and implementing efficient processes.

Scott Oppenheim completed their high school education at George W. Hewlett High School from 1982 to 1986. Scott then went on to pursue a Bachelor of Arts (B.A.) degree in Legal and Political Communications from Queens College of the City University of New York, where they studied from 1986 to 1991.

Links

Previous companies

Novartis logo

Timeline

  • Senior Director Of Supply Chain

    April, 2022 - present